Cost-effectiveness analysis of axicabtagene ciloleucel vs. salvage chemotherapy for relapsed or refractory adult diffuse large B-cell lymphoma in China
Na Li, Bin Zheng, Hongfu Cai, Ting Yang, Yunda Hong, Maobai Liu, Jianda Hu
Topics & Concepts
MedicineOncologyInternal medicineCost-effectiveness analysisCost effectivenessRisk analysis (engineering)CAR-T cell therapy researchLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research